Transdermal estrogen ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 299 | 嚢胞性線維症 | 1 |
299. 嚢胞性線維症
臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05704036 (ClinicalTrials.gov) | March 2023 | 10/1/2023 | Estrogen Patches for Adolescent and Young Adult Women With Cystic Fibrosis | Transdermal Estradiol for Adolescent and Young Adult Women With CF | Cystic Fibrosis;Hypoestrogenism | Drug: Transdermal estrogen;Drug: Placebo patch;Drug: Progesterone;Drug: Placebo pill | Johns Hopkins University | Cystic Fibrosis Foundation | Recruiting | 16 Years | 30 Years | Female | 75 | Phase 4 | United States |